Tandem Diabetes (TNDM.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Nov21

Bernstein Analyst Maintains Hold Rating on Tandem Diabetes Care

00:52

Nov11

Morgan Stanley Raises Tandem Diabetes Care's Target Price to $17.00

19:11

Nov10

Tandem Diabetes Care Inc. Receives FDA Approval for Android Version of Tandem Mobi Mobile App

13:31

Nov7

Stifel Nicolaus Reiterates Hold Rating on Tandem Diabetes Care

15:52

William Plovanic Maintains Buy Rating on Tandem Diabetes Care

13:51

Analyst Maintains Tandem Diabetes Care Hold Rating

12:32

Schedules & Filings

Schedules

Filings

Nov6

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 249.25 M, Net Income -21.17 M, EPS -0.3128

Aug6

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 240.68 M, Net Income -52.4 M, EPS -0.7815

Apr30

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 234.42 M, Net Income -130.56 M, EPS -1.966

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change